SCHEMBL6380947

SCHEMBL6380947

CCCCCCCOC[C@H]1OC(OCc2ccccc2)[C@H](OCC)[C@@H](OCCC)[C@@H]1O

nearest known ligand 0.52

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ SSTR5 P35346 7/20 0.52
▸ SSTR4 P31391 7/20 0.52
▸ SSTR1 P30872 6/20 0.52
▸ SSTR2 P30874 6/20 0.52
▸ SSTR3 P32745 6/20 0.52
▸ TACR1 P25103 4/20 0.50
▸ ADRB2 P07550 1/20 0.43
▸ TNF P01375 1/20 0.40
▸ SELP P16109 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6381047 0.90 SSTR4 (0.65) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6385770 0.87 SSTR1 (0.45) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6380648 0.85 TNF (0.50) TACR1TNF
SCHEMBL6385509 0.84 SSTR1 (0.55) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6381530 0.83 SSTR5 (0.50) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6380549 0.82 SSTR5 (0.52) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6382174 0.81 TACR1 (0.41) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6385225 0.79 NT5E (0.42) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL6380615 0.79 TNF (0.60) SSTR5SSTR4SSTR1SSTR2SSTR3
SCHEMBL23742931 0.79 NT5E (0.51) SSTR5SSTR4SSTR1SSTR2SSTR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1001961-B1 SUBSTITUTED TETRAHYDROPYRANE DERIVATIVES AND METHOD FOR PRODUCING SAME AVENTIS PHARMA GMBH (DE) 2005-01-26 — — EP disclosed
US-6756489-B1 PROTECTED MONOSACCHARIDES HAVING AN ALLYL PROTECTING GROUP, A SILANE-PROTECTED HYDROXY GROUP AND A CARBOXY OR AMIDE CONTAINING PROTECTIVE GROUP; EASILY MADE BY COMBINATORIAL CHEMISTRY; APPLICATIONS TO AUTOIMMUNE AND CANCER AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2004-06-29 — — US disclosed
Send feedback